KEGG   DISEASE: IgA nephropathy
Entry
H01581                      Disease                                
Name
IgA nephropathy;
Berger disease
Description
Primary IgA nephropathy is an immune-complex-mediated glomerulonephritis defined immunohistologically by the presence of glomerular IgA deposits accompanied by a variety of histopathologic lesions. It is known to be the most prevalent primary chronic glomerular disease worldwide. Because of the critical interaction between an intrinsic antigen (galactose-deficient IgA1) and circulating anti-glycan antibodies, IgA nephropathy can be considered an autoimmune disease. Since the features of IgA nephropathy identified by light microscopy are nonspecific, immunofluorescence or immunoperoxidase studies demonstrating a predominant deposition of IgA are essential to establish a definitive diagnosis of IgA nephropathy. Genetic factors undoubtedly influence the pathogenesis of IgA nephropathy. Genomewide association studies have identified common susceptibility loci in the absence of a priori mechanistic hypotheses.
Category
Immune system disease; Urinary system disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
 21 Symptoms, signs or clinical findings, not elsewhere classified
  Symptoms, signs or clinical findings of the genitourinary system
   Clinical findings in specimens from the urinary system
    MF8Y  Other specified clinical findings in specimens from the urinary system
     H01581  IgA nephropathy
Drug
Sparsentan [DR:D11776]
Other DBs
ICD-11: MF8Y
ICD-10: N02.8
MeSH: D005922
Reference
  Authors
Donadio JV, Grande JP
  Title
IgA nephropathy.
  Journal
N Engl J Med 347:738-48 (2002)
DOI:10.1056/NEJMra020109
Reference
  Authors
Wyatt RJ, Julian BA
  Title
IgA nephropathy.
  Journal
N Engl J Med 368:2402-14 (2013)
DOI:10.1056/NEJMra1206793
LinkDB

» Japanese version

DBGET integrated database retrieval system